SPOTLIGHT: Can Florida woo biotechs?

Florida's success in luring three major research institutions to the Sunshine State has triggered a heated argument over its prospects in attracting new biotech companies. Some say that the deals insure the state's biotech future while others argue that biotechnology has already past its boom stage. Article

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.